GlassScriptPhysician profile
Kyong H Kim
NPI 1124009303
$22,833.28
in general payments reported to CMS, 2019-2025
49 companies · $2,895 in 2025
The $2,895 reported for 2025 was more than what 84% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,670 · 2020: $5,158 · 2021: $1,119 · 2022: $5,205 · 2023: $3,015 · 2024: $1,771 · 2025: $2,895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,994 · Travel and Lodging: $1,686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,994.39 |
| Travel and Lodging | $1,686.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flowonix Medical Incorporated | $5,580.42 | 2019-2020 | |
| Boston Scientific Corporation | $4,519.13 | 2019-2025 | Spectra Wavewriter, Intracept, General - Pain Management |
| Nalu Medical, INC. | $1,918.30 | 2021-2025 | Nalu Neurostimulation System |
| Nevro Corp. | $1,744.50 | 2019-2024 | Senza |
| Saluda Medical Americas, INC. | $1,581.93 | 2023-2025 | Evoke, Evoke Scs |
| Relievant Medsystems, INC. | $1,444.15 | 2022-2023 | Intracept |
| Abbott Laboratories | $1,236.00 | 2019-2025 | Proclaim |
| Globus Medical, INC. | $987.01 | 2025 | Senza |
| Collegium Pharmaceutical, INC. | $561.82 | 2019-2025 | Xtampza, Belbuca |
| Medtronic, INC. | $423.41 | 2022-2024 | Intellis Adaptivestim, Vanta Adaptivestim |
| Orexo US, INC. | $243.98 | 2021-2024 | Zubsolv |
| Daiichi Sankyo INC. | $204.12 | 2019 | |
| Abbvie INC. | $200.80 | 2021-2023 | |
| Virtus Pharmaceuticals LLC | $190.92 | 2024-2025 | Levorphanol Tartrate |
| Inari Medical, INC. | $175.73 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyong Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.